Natural killer cells suppress full cycle HCV infection of human hepatocytes

Journal of Viral Hepatitis

Volumn 15, Issue 12, 2008, Pages 855-864

  Wang, S H ^a,b   Huang, C X ^b   Ye, L ^a   Wang, X ^a   Song, L ^a   Wang, Y J ^a   Liang, H ^a   Huang, X Y ^b   Ho, W Z ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Hepatitis C virus; Innate immunity; Interferon; STAT

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; STAT1 PROTEIN; STAT2 PROTEIN; VIRUS RNA;

ADULT; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ADULT; CELLS, CULTURED; COCULTURE TECHNIQUES; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; INTERFERONS; KILLER CELLS, NATURAL; MALE; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 56549104664     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01014.x     Document Type: Article

References (35)

1. Nuti S, Rosa D, Valiante NM et al. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998 28 (11 3448 3455.
2. Biron CA. Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 1997 9 (1 24 34.
3. Chang KM. Immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 2003 7 (1 89 105.
4. Fiore G, Angarano I, Caccetta L et al. In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C. Eur J Gastroenterol Hepatol 1997 9 (5 491 496.
5. Kawarabayashi N, Seki S, Hatsuse K et al. Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000 32 (5 962 969.
6. Yonekura K, Ichida T, Sato K et al. Liver-infiltrating CD56 positive T lymphocytes in hepatitis C virus infection. Liver 2000 20 (5 357 365.
7. Bonavita MS, Franco A, Paroli M et al. Normalization of depressed natural killer activity after interferon-alpha therapy is associated with a low frequency of relapse in patients with chronic hepatitis C. Int J Tissue React 1993 15 (1 11 16.
8. Corado J, Toro F, Rivera H, Bianco NE, Deibis L, De Sanctis JB. Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin Exp Immunol 1997 109 (3 451 457.
9. Le Page C, Genin P, Baines MG, Hiscott J. Interferon activation and innate immunity. Rev Immunogenet 2000 2 (3 374 386.
10. Appasamy R, Bryant J, Hassanein T, Van Thiel DH, Whiteside TL. Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C. Clin Immunol Immunopathol 1994 73 (3 350 357.
11. Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002 195 (1 43 49.
12. Crotta S, Stilla A, Wack A et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002 195 (1 35 41.
13. Duesberg U, Schneiders AM, Flieger D, Inchauspe G, Sauerbruch T, Spengler U. Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C. J Hepatol 2001 35 (5 650 657.
14. Ortaldo JR, Oldham RK, Cannon GC, Herberman RB. Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line. J Natl Cancer Inst 1977 59 (1 77 82.
15. Par G, Rukavina D, Podack ER et al. Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection. J Hepatol 2002 37 (4 514 522.
16. Morishima C, Paschal DM, Wang CC et al. Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 2006 43 (3 573 580.
17. Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho WZ. Natural killer cells inhibit hepatitis C virus expression. J Leukoc Biol 2004 76 (6 1171 1179.
18. Lindenbach BD, Evans MJ, Syder AJ et al. Complete replication of hepatitis C virus in cell culture. Science 2005 309 (5734 623 626.
19. Wakita T, Pietschmann T, Kato T et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005 11 (7 791 796.
20. Zhong J, Gastaminza P, Cheng G et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 2005 102 (26 9294 9299.
21. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, Rice CM. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 2006 80 (4 1734 1741.
22. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994 8 (4 652 658.
23. Yang JH, Lai JP, Douglas SD, Metzger D, Zhu XH, Ho WZ. Real-time RT-PCR for quantitation of hepatitis C virus RNA. J Virol Methods 2002 2 : 119 128.
24. Li Y, Zhang T, Douglas SD et al. Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol 2003 163 (3 1167 1175.
25. Frese M, Schwarzle V, Barth K et al. Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 2002 35 (3 694 703.
26. Zhang T, Lin RT, Li Y et al. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines. Hepatology 2005 42 (4 819 827.
27. Takaoka A, Yanai H. Interferon signalling network in innate defence. Cell Microbiol 2006 8 (6 907 922.
28. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004 75 (2 163 189.
29. Liu C, Zhu H, Tu Z, Xu YL, Nelson DR. CD8+ T-cell interaction with HCV replicon cells: evidence for both cytokine- and cell-mediated antiviral activity. Hepatology 2003 37 (6 1335 1342.
30. Takaoka A, Mitani Y, Suemori H et al. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science 2000 288 (5475 2357 2360.
31. Hengel H, Koszinowski UH, Conzelmann KK. Viruses know it all: new insights into IFN networks. Trends Immunol 2005 26 (7 396 401.
32. Fitzgerald KA, McWhirter SM, Faia KL et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003 4 (5 491 496.
33. Civas A, Island ML, Genin P, Morin P, Navarro S. Regulation of virus-induced interferon-A genes. Biochimie 2002 84 (7 643 654.
34. Sato M, Hata N, Asagiri M, Nakaya T, Taniguchi T, Tanaka N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 1998 441 (1 106 110.
35. Foy E, Li K, Wang C et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003 300 (5622 1145 1148.